focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,904.00
Bid: 4,902.00
Ask: 4,908.00
Change: -8.00 (-0.16%)
Spread: 6.00 (0.122%)
Open: 4,906.00
High: 4,910.00
Low: 4,902.00
Prev. Close: 4,912.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

10 Apr 2008 07:00

Intertek Group PLC10 April 2008 Stock Exchange Release 10 April 2008, 7am London, UK Intertek acquires 4-Front Research Intertek Group plc (Intertek), the leading provider of quality and safetysolutions to a wide range of industries around the world, announces theacquisition of 4-Front Research Limited, 4-Front Research UK Limited, 4 FrontResearch SAS (France) and Four Front Research (India) Pvt Limited), (together"4-Front Research"), a provider of testing services for consumer healthcare andrelated products. Intertek purchased 4-Front Research from owner Jon Holt for an initial cashconsideration of GBP 6 million and an estimated deferred consideration of GBP4.4 million payable in June 2009, and based on 2008 performance. 4-Front Research provides analytical support for clinical research studies oncosmetic, personal care, functional food, and over-the-counter (OTC)pharmaceutical and medical products. Customers, which include national andinternational consumer product brands, use 4-Front Research's services forproduct development, support, and to verify promotional statements. Products areevaluated for dermatological, allergenic, sunlight or dental effects amongstothers. With seven sites in England and sites in Hyderabad, India and Paris, France,4-Front employs 110 people and will form part of Intertek's Consumer Goodsdivision. Wolfhart Hauser, Chief Executive Officer of Intertek, commented: "4-Front Research adds new high-value services to support our consumerhealthcare customers in helping them to develop and monitor products. Theacquisition also gives us a strategic position to support future and growingdemand for consumer healthcare products within India and other Asian marketswith its locations in India, supported by the European network." -ends- Contacts Aston Swift / Sarah Ogilvie Intertek Telephone: +44 (0) 20 7396 3400 aston.swift@intertek.com / sarah.ogilvie@intertek.com Richard Mountain / Sophie Kernon, Financial Dynamics Telephone: +44 (0) 20 7269 7121 richard.mountain@fd.com / sophie.kernon@fd.com Notes to Editors ABOUT INTERTEK Intertek (LSE: ITRK) is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 21,000 people in 110 countries around the world. www.intertek.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.